The role of Helicobacter pylori urease in opsonization by human complement was investigated. H. pylori wild type strain N6 and isogenic mutants lacking either the large urease subunit (UreB) or an accessory urease protein (UreG) were incubated with different sera. C3b bound to the bacteria was measured by specific staining and flow cytometry. As compared with opsonization of N6 and the UreG-lacking mutant, opsonization of the UreB-lacking mutant was significantly increased after incubation with sera from both H. pylori uninfected ( ) or infected ( ) persons. However, when sera from uninfected persons were P ! .001 P ! .05 used, effective opsonization of this mutant proved to be dependent mainly on the classical pathway of complement activation. Irrespective of the serum used, opsonization values were very low after selective inactivation of the classical or the alternative pathway. Reduced opsonization of the urease-expressing strains could, to some extent, result from degradation of bound C3b.
The role of Helicobacter pylori urease in opsonization by human complement was investigated. H. pylori wild type strain N6 and isogenic mutants lacking either the large urease subunit (UreB) or an accessory urease protein (UreG) were incubated with different sera. C3b bound to the bacteria was measured by specific staining and flow cytometry. As compared with opsonization of N6 and the UreG-lacking mutant, opsonization of the UreB-lacking mutant was significantly increased after incubation with sera from both H. pylori uninfected ( ) or infected ( ) persons. However, when sera from uninfected persons were P ! .001 P ! .05 used, effective opsonization of this mutant proved to be dependent mainly on the classical pathway of complement activation. Irrespective of the serum used, opsonization values were very low after selective inactivation of the classical or the alternative pathway. Reduced opsonization of the urease-expressing strains could, to some extent, result from degradation of bound C3b.
Helicobacter pylori colonizes the human gastric mucosa and causes gastritis, duodenal ulcer, and gastric carcinoma [1] . Despite a specific humoral and cellular immune response, the infection shows lifelong persistence in the majority of cases [2] . It is still unclear which bacterial factors contribute to this phenomenon.
The bacterium produces large amounts of urease, which, in contrast to other bacterial ureases, is partly surface-associated [3] . Urease is necessary for initial colonization of the mucosa protecting the acid-sensitive bacterium against gastric juice [4] . However, the fact that isogenic non-urease-producing mutants are unable to colonize gnotobiotic piglets with neutralized stomach pH [5] plus the fact that the bacterium continuously produces urease after colonization of gastric mucus at nearly neutral pH suggest that the enzyme might have additional functions.
A recent study showed that the presence of H. pylori urease inhibits phagocytosis of the bacterium by human granulocytes by a mechanism largely independent of ammonia production [6] . The aim of this study was to investigate whether H. pylori opsonization is affected by the presence of urease. This was done by measuring C3b binding on H. pylori by a novel flow cytometric technique utilizing fluorescein isothiocyanate (FITC)-labeled antibodies against the C3b subunits C3c and C3d. In case of degradation and inactivation of bound C3b to soluble C3c and remaining C3d, staining with anti-C3c should diminish, as compared with anti-C3d staining.
Materials and Methods
Bacterial strains. H. pylori parental strain N6, isogenic mutant N6ureB::TnKm not producing the large urease subunit UreB, and isogenic mutant N6ureG::TnKm lacking the urease accessory protein UreG were provided by A. Labigne (Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, Paris) [7] . Bacteria were grown at 37ЊC in Brucella broth (Difco, Detroit) containing 7% fetal calf serum (Life Technologies Gibco BRL, Gaithersburg, MD) and selective supplement (Unipath Limited Oxoid, Basingstoke, UK), under microaerobic conditions. Serology. Specific IgG antibodies against H. pylori were determined by a fluorescence-immunoassay (Helori-test IgG; Eurospital, Trieste, Italy).
Sera. Anti-H. pylori IgG-positive or -negative sera were obtained from members of the laboratory staff. Sera depleted of either C2 or factor B were purchased from Sigma (St. Louis). For inactivation of the classical pathway of complement activation (CPCA), EGTA and MgCl 2 (10 mM) were added [8] . For inactivation of the alternative pathway of complement activation (APCA), sera were heated at 50ЊC for 30 min [8] . To inactivate complement completely, sera were heated at 56ЊC for 30 min or EDTA (10 mM) was added [8] . A hypogammaglobulinemia serum (440 mg/dL IgG, !33 mg/dL IgA, !30 mg/dL IgM) containing H. pylori-specific IgG antibodies was also used.
Bacterial staining. H. pylori were harvested from a 48-h broth culture and washed once with PBS, and the bacterial suspension was adjusted to an A 550 of 0.5 with PBS. Suspensions were incu- . * for N6ureB::TnKm vs. N6 or N6ureG::TnKm; Bars ϭ SE P ! .05 ** for N6ureB::TnKm vs. N6 or N6ureG::TnKm. P ! .001 bated at 37ЊC in a shaking water bath in the presence of 2%, 5%, or 10% human serum. At several time points, 50-mL aliquots were collected in a microwell plate on ice. The plates were centrifuged (2500 g), and pellets were washed twice with PBS containing 1% bovine serum albumin (BSA). Antibody preparations (Dako, Glostrup, Denmark) differed to some extent in their immunoglobulin concentrations (titer of anti-C3c was 1.52 times higher than that of anti-C3d), but the molar ratio of FITC to protein was similar. For optimal staining, the most appropriate antibody dilutions in PBS-BSA appeared to be 1:200 for anti-C3c-FITC and 1:100 for anti-C3d-FITC. Staining was done by resuspending bacterial pellets in 100 mL of antibody dilution and incubating for 45 min at room temperature. Plates were centrifuged and washed once with PBS-BSA. The bacteria were resuspended in PBS-BSA, diluted with Isoton II (Coulter Euro Diagnostics, Krefeld, Germany), and analyzed.
Flow cytometry. Measurements were performed on an EPICS XL-MCL (Coulter, Hialeah, FL). The H. pylori cell population was gated by means of forward and sideward light scatter. Caution was used to distinguish bacterial cells from electronic noise. Green fluorescence emission of the bacteria was monitored. Stability of the optical and fluid system was controlled by DNA-check beads (Coulter).
Statistical analysis. Differences of means were tested for statistical significance by means of multivariate analysis (non-full rank linear model) using SPSS (Chicago) for Windows 7.0. Degrees of freedom were adjusted by the Greenhouse-Geisser test. Multiple pairwise comparisons of means were done by Bonferroni's test. Statistical significance was set at . P ϭ .05
Results
Opsonization of the mutant N6ureB::TnKm resulted in dramatically increased anti-C3c staining in the presence of anti-H. pylori IgG-negative sera: After 10 min of incubation with 5% figure 1A ). In these sera, inhibition of opsonization P ! .001 due to urease was highly significant ( ) at all serum P ! .001 concentrations ( figure 1B) . In contrast, both mutants and the parental strain were opsonized to a high extent in the presence of anti-H. pylori IgG-positive sera. However, values obtained with N6ureB::TnKm were still higher than those with N6 or N6ureG::TnKm, with differences being statistically significant ( ) in the presence of 2% serum after 10 min (data not P ! .05 shown) and 15 min ( figure 1D ) or 5% serum after 10 min of incubation ( figure 1C) . With anti-H. pylori IgG-positive sera, inhibition of opsonization was dependent on serum concentration being less pronounced at higher concentrations ( figure 1D ). Using the serum of the H. pylori-infected person with hypogammaglobulinemia, values for N6 or N6ureG::TnKm were higher than those for anti-H. pylori IgG-negative sera and lower than those for positive sera (data not shown).
Inactivation of APCA by heating sera at 50ЊC for 30 min or the use of a complement factor B-deficient serum resulted in an extensive reduction of anti-C3c binding to all strains, irrespective of the presence or absence of H. pylori-specific IgG antibodies in the serum used. However, values for N6ureB:: TnKm still were considerably higher than those for N6 or N6ureG::TnKm, especially in anti-H. pylori IgG-negative sera (table 1). We were surprised that inactivation of CPCA after the addition of EGTA and MgCl 2 to sera not containing H. pylori-specific antibodies resulted in a dramatic reduction of anti-C3c binding to N6ureB::TnKm, which was also confirmed using C2-deficient serum. With respect to N6 or N6ureG:: TnKm, use of these sera resulted in almost complete inhibition of antibody binding. Furthermore, when CPCA was inactive, values for anti-H. pylori IgG-positive sera were very similar to those for negative sera (table 1) . Irrespective of the complement pathway being inactivated or the serum used, N6ureB:: TnKm showed significantly higher ( ) values than did N6 P ! .05 or N6ureG::TnKm, except when APCA-inactivated sera from infected persons were used ( ). P 1 .05 In addition to anti-C3c staining, opsonized bacteria were stained in parallel samples using anti-C3d FITC-labeled antibodies. When opsonization was performed using anti-H. pylori IgG-positive sera, anti-C3d staining was ∼4-fold weaker than that using anti-C3c, regardless of the bacterial strain (parental or mutant). Because preliminary experiments had shown that this was not a concentration effect (data not shown) and because the FITC-to-protein molar ratio was similar in both antibody preparations, the reason could be the size of the C3c subunit being larger than C3d. Thus, anti-C3c antibodies may recognize and bind to more epitopes than do anti-C3d antibodies. In the presence of anti-H. pylori IgG-negative sera, this 1:4 ratio could be observed only with the urease-deficient mutant N6ureB::TnKm; no considerable difference for N6 or N6ureG::TnKm could be seen between anti-C3d and anti-C3c staining (table 1) .
Sera heated to 56ЊC for 30 min or supplemented with EDTA (to eliminate complement activity) were used as negative controls for opsonization, producing values (table 1) similar to those obtained when analyzing unstained bacteria (autofluorescence), irrespective of serum concentration and incubation time.
Discussion
H. pylori urease (550 kDa) consists of the two distinct subunits, UreA (29 kDa) and UreB (66 kDa), at a 1:1 ratio [9] . Using immunoblot, none of the subunits could be detected by the isogenic mutant N6ureB::TnKm [7] , suggesting either degradation of UreA or instability of the transcript. This mutant, possessing no urease, was opsonized more efficiently by C3b than parental strain N6 or mutant N6ureG::TnKm producing an enzymatically inactive protein. These findings suggest that urease inhibits opsonization of H. pylori and, furthermore, that this effect is independent of enzymatic activity because opsonization of N6ureG::TnKm was very similar to that of N6. Previous studies using indirect methods, such as phagocytosis, killing, and production of reactive oxygen metabolites by human neutrophils, showed controversial results concerning the role of specific antibodies for H. pylori opsonization [8, 10] . This study, which utilized direct staining of bound C3b, clearly demonstrates the importance of these antibodies for sufficient opsonization of the wild type strain N6 ( after in-2.01 ‫ע‬ 0.43 cubation with anti-H. pylori IgG-negative sera vs. 71.0 ‫ע‬ using positive sera). 14.8
When anti-H. pylori IgG-positive sera were used for bacterial opsonization, an inverse proportionality was observed between serum concentration and inhibition of opsonization due to the presence of urease: the higher the serum concentration, the lower the observed inhibition. Using these sera, the difference in anti-C3c binding between N6ureB::TnKm and N6 or N6ureG::TnKm was less pronounced. However, this difference became highly significant ( ) when anti-H. pylori P ! .001 IgG-negative sera were used.
Inactivation of CPCA in these sera or the use of an anti-H. pylori IgG-negative, C2-deficient serum resulted in a dramatic decrease of anti-C3c binding to N6ureB::TnKm (83.70 ‫ע‬ 4.27 vs.
or vs.
). Additional experiments us-1.35 ‫ע‬ 0.30 1.23 ‫ע‬ 0.31 ing IgG-depleted sera from uninfected persons showed a reduction of anti-C3c binding to the mutant of ∼4-fold compared with native sera. This finding suggests that the high values obtained for anti-C3c binding to N6ureB::TnKm using anti-H. pylori IgG-negative sera can be explained by activation of the CPCA mainly through nonspecific antibodies rather than direct C1q binding to H. pylori, as suggested elsewhere [11] . This activation seems to be largely inhibited in the presence of urease.
Irrespective of the presence or absence of anti-H. pylori IgG antibodies in the serum used for opsonization, inactivation of CPCA almost completely abolished binding of anti-C3c to the surface of N6 or N6ureG::TnKm, indicating the importance of the CPCA for opsonization of H. pylori. The fact that N6ureB::TnKm could still be opsonized, although to a low extent, suggests that the absence of urease may enable direct activation of the alternative pathway through bacterial antigens (e.g., lipopolysaccharide). In this context, it should be mentioned that H. pylori lipopolysaccharide, especially the smooth type, exhibits rather weak biologic activity compared with lipopolysaccharides of other bacterial species [12] .
As expected, selective inactivation of the APCA or the use of a complement factor B-deficient serum resulted in poor opsonization of the mutants or the parental strain. However, values for anti-C3c binding obtained with N6ureB::TnKm were higher than those for N6 or N6ureG::TnKm. The difference was more pronounced in the absence of H. pylori-specific IgG antibodies.
Inhibition of anti-C3c binding to H. pylori, as shown in the presence of urease, may be due to impaired C3b binding to the bacterium or to degradation of bound C3b to soluble C3c and C3d remaining on the bacterial surface. To elucidate the mechanism by which urease affects anti-C3c binding, staining with anti-C3d was also performed. In the absence of urease or in the presence of H. pylori-specific IgG antibodies, the binding ratio of anti-C3c to anti-C3d binding ratio was ∼4. However, when we used anti-H. pylori IgG-negative sera, the strains expressing urease showed similar staining with either antibody used. This was due to a second, smaller bacterial population with higher mean fluorescence emerging after anti-C3d staining. Although this finding does not provide direct evidence for degradation of bound C3b, it could, however, be the result of better anti-C3d binding after dissociation of C3c. Hence, H. pylori urease may, to a low extent, be responsible for degradation of bound C3b. However, the main mechanism by which the protein prevents opsonization could be the inhibition of antibody binding to bacterial surface antigens and, furthermore, the failure of alternative pathway activation by these antigens. In any case, the reduction of bound C3b would consequently diminish the C3bBb-convertase-mediated feedback mechanism. Of interest, similar results were obtained in opsonization experiments with Campylobacter fetus expressing surface-associated S-layer proteins [13] . However, the nucleotide and amino acid sequence of these proteins and H. pylori urease appear to be unrelated.
In summary, these data indicate that the presence of specific antibodies is necessary for sufficient opsonization of H. pylori and that urease inhibits opsonization, especially when these antibodies are absent or available only in low concentrations. Taking into consideration the low IgG concentration in the gastric mucosa, these findings could explain the poor H. pylori opsonization in vivo described elsewhere [14, 15] . Furthermore, the data support the hypothesis that H. pylori urease, in addition to having enzymatic activity, exhibits an immunomodulatory function.
